Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03779425 · ClinicalTrials.gov registry record · NA

VR-Based Physical Therapy Pilot Study

A NA study, sponsored by Dartmouth-Hitchcock Medical Center.

Completed
Registry status
NA
Development phase
31
Enrollment target

NCT03779425: Completed NA study, sponsored by Dartmouth-Hitchcock Medical Center.

NCT03779425 is a NA study that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 31 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03779425, a NA study, has completed, sponsored by Dartmouth-Hitchcock Medical Center.

COMPLETED
Registry status
NA
Development phase
31 participants
Enrollment target

Study Summary

The purpose of this study is to evaluate the feasibility and acceptability of using the virtual reality-based physical therapy platform in patients with extremity fracture.

Primary Outcome

Patient satisfaction with the virtual reality based physical therapy platform. Patient satisfaction will be assessed using a questionnaire created for this study.

Interventions

  • OTHER Virtual Reality Physical Therapy

Trial Details

FieldValue
Enrollment Target 31 participants
Start Date 2019-03-09
Est. Completion 2019-12-20
Phase NA
Dartmouth-Hitchcock Medical Center

427 total trials

What the finished NCT03779425 record still lists

NCT03779425 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 31 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 1 intervention - of which Virtual Reality Physical Therapy is the first listed.

NCT03779425 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03779425 about?

NCT03779425 is a clinical study titled "VR-Based Physical Therapy Pilot Study". The purpose of this study is to evaluate the feasibility and acceptability of using the virtual reality-based physical therapy platform in patients with extremity fracture.

What is the current status of trial NCT03779425?

This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2019-03-09. Estimated completion is 2019-12-20.

What interventions are being tested in trial NCT03779425?

The interventions under investigation include: Virtual Reality Physical Therapy (OTHER).

Who is sponsoring clinical trial NCT03779425?

This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03779425's enrollment target sits among peer trials

31 1592nd of 2000 higher than 408 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02932618 · 31 participants · Phase 3

    A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)

  • NCT03482297 · 31 participants · Phase 1

    Automated Abdominal Binder for Orthostatic Hypotension

  • NCT04016389 · 31 participants · NA

    FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery

  • NCT04211675 · 31 participants · Phase 1

    NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03779425, the US trial registry maintained by the National Library of Medicine. NCT03779425 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.